GE HealthCare Wants to Turn Mammography Into a Software Business

GE HealthCare (GEHC)’s recent moves show it is shifting from being primarily a hardware vendor to becoming a full imaging-software and services provider.

With its newly authorized Pristina Recon DL for mammography and the planned acquisition of Intelerad for US$ 2.3 billion, GE is positioning itself to capture recurring software revenue.

GE’s mammography upgrade

Yesterday, GE announced that the Food and Drug Administration (FDA) granted Premarket Authorization to Pristina Recon DL, a deep-learning powered 3D mammography reconstruction system. GE says the system uses two sequential deep-learning models: the first reconstructs high-fidelity 3D volumes with fewer artifacts and noise; the second enhances clinically relevant features in a synthesized 2D view, all without increasing radiation dose.

In internal readings, breast radiologists reportedly preferred images produced by Recon DL in 99.1% of reviews compared with conventional reconstruction. GE’s leadership described the move as part of a broader commitment to AI-driven women’s health imaging. “By applying advanced deep-learning technologies, we’re shaping the future of breast imaging, one defined by uncompromised image quality, faster workflows, and greater confidence in early cancer detection,” said Jyoti Gupta, President and CEO of Women’s Health and X-ray at GE HealthCare.